In addition, the Company announced that following
Post# of 148101
(Total Views: 495)
Posted On: 10/30/2024 8:57:08 AM
Quote:
In addition, the Company announced that following promising initial results from its preclinical study with SMC, it has commissioned the lab to conduct two follow-up studies to confirm and extend the observation of fibrosis reversal observed in the study concluded in September 2024. Both follow-up studies are underway, with results expected in early 2025.
Results in early 2025 - awesome - was not aware we were moving at that kind of pace.
Nice!
(12)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼